ResMed | RMD - 债务

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.55B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	债务	更改		日
Ansell	USD 805.6M		51.6M	2025-06
Artivion	USD 317.78M		619K	2024-12
AtriCure	USD 73.38M		3.35M	2025-12
Baxter International	USD 9.78B		68M	2025-12
Cochlear	AUD 235.7M		10.9M	2025-06
Cooper Companies	USD 2.51B		27M	2025-09
CSL	USD 11.96B		219M	2024-12
Dexcom	USD 1.24B		900K	2026-03
Edwards Lifesciences	USD 600M		105.4M	2026-03
Globus Medical	USD 118.66M		687K	2025-12
Haemonetics	USD 1.22B		5K	2025-12
Idexx Laboratories	USD 1.11B		129.39M	2026-03
Inogen	USD 0		0	2022-06
Insulet	USD 949.2M		65.6M	2025-12
Integra LifeSciences	USD 2.04B		6.27M	2026-03
Intuitive Surgical	USD 0		0	2025-03
Masimo	USD 485.9M		100.3M	2026-03
Medtronic	USD 28.07B		1.03B	2025-12
Philips	EUR 7.81B		574M	2025-12
Ramsay Health Care	AUD 12.12B		864.4M	2025-06
ResMed	USD 847.72M		1.37M	2025-12
Sigma Healthcare	AUD 137.64M		1.01M	2024-07
Sonic Healthcare	AUD 4.8B		282.9M	2024-12
Steris	USD 2.05B		4.8M	2025-12
Teleflex	USD 2.73B		43.5M	2025-12
Thermo Fisher Scientific	USD 39.39B		3.7B	2025-12